Transcatheter Heart Valve Replacement Market Size, Share & Trends Analysis | Global | 2026-2032 | MedCore | Includes: Aortic and Pulmonary Valve Replacement

Year: 2024
Scope: 10 Years
Region: Global
Published Date: 04/12/2024
Type: MedCore

Product Description

Overall, the global transcatheter heart valve replacement market was valued at $7 billion in 2023. This is expected to increase over the forecast period at a CAGR of 6.8% to reach $11 billion.

The full report suite on the global market for transcatheter heart valve replacement (THVR) includes artificial valves placed in a minimally invasive catheter procedure to the aortic and pulmonary valves.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2030, and Historical Data to 2020
Recent Mergers & Acquisitions
Disease Overview
Company Profiles, Product Portfolios, and SWOT for Top Competitors

TRANSCATHETER HEART VALVE REPLACEMENT MARKET INSIGHTS

Global trans catheter heart valve replacement market

Transcatheter aortic valve implantation (TAVI) is a well-established procedure, whereas transcatheter pulmonary valve replacement (TPVR) is a newer innovation still confined to a niche market controlled by just two companies, limiting its expansion prospects. Conversely, the aortic valve replacement segment, with its variety of approved devices, continues to dominate the heart valve replacement market. TAVI is increasingly recognized as a safer alternative to traditional surgical options, including tissue and mechanical heart valve implants, and is expected to maintain its growth trajectory.

MARKET SHARE INSIGHTS

Global transcatheter heart valve replacement market

In 2023, Edwards Lifesciences solidified its position as a leader in the THVR device market. Their flagship products, the SAPIEN 3®, SAPIEN XT®, and CENTERA® valves, are pivotal in aortic and pulmonary valve replacements globally, securing a robust market presence.

Meanwhile, Medtronic has shown growth in the THVR space with its CoreValve™ Evolut™ Pro and R systems, focusing more on this segment after exiting the ventricular assist device market.

Boston Scientific, ranking third, sustains its market foothold with the ACURATE TA™ and ACURATE neo™/TF™ systems, stabilizing its position post the LOTUS™ recall and amid fierce competition from leading players.

MARKET SEGMENTATION SUMMARYH

Transcatheter Aortic Valve Replacement
Transcatheter Pulmonary Valve Replacement

RESEARCH SCOPE SUMMARY

Report Attribute	Details
Regions	North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2023
Forecast	2024-2030
Historical Data	2020-2023
Quantitative Coverage	Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage	COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

FREE Sample Report

Transcatheter Heart Valve Replacement Market

10.1 Executive Summary

10.1.1 Global Transcatheter Heart Valve Replacement Market Overview

10.1.2 Competitive Analysis

10.1.3 Procedures Included

10.1.4 Markets Included

10.1.5 Regions Included

10.2 Introduction

10.3 Procedure Numbers

10.3.1 Total Transcatheter Heart Valve Replacement Procedures

10.3.2 Transcatheter Aortic Valve Replacement Procedures

TAVR with Cerebral Embolic Protection Procedures

TAVR without Cerebral Embolic Protection Procedures

10.3.3 Transcatheter Pulmonary Valve Replacement Procedures

10.4 Market Overview

10.4.1 By Segment

10.4.2 By Region

10.5 Market Analysis and Forecast

10.5.1 Total Transcatheter Heart Valve Replacement Market

10.5.2 Transcatheter Aortic Valve Replacement Market

10.5.3 Transcatheter Pulmonary Valve Replacement Market

10.6 Drivers and Limiters

10.6.1 Market Drivers

10.6.2 Market Limiters

10.7 Competitive Market Share Analysis

Companies Included

Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Venus MedTech
Microport
Jiecheng Medical
Others

Chart List

Chart 10‑1: Transcatheter Heart Valve Replacement Market, Global, 2023 & 2030

Chart 10‑2: Transcatheter Heart Valve Replacement Procedures, Global, 2023

Chart 10‑3: Transcatheter Heart Valve Replacement Procedures by Segment, Global, 2020 – 2030

Chart 10‑4: Transcatheter Heart Valve Replacement Market by Protection, Global, 2020 – 2030

Chart 10‑5: Transcatheter Heart Valve Replacement Market by Segment, Global, 2020 – 2030

Chart 10‑6: Transcatheter Heart Valve Replacement Market by Region, Global, 2020 – 2030

Chart 10‑7: Leading Competitors, Transcatheter Heart Valve Replacement Market, Global, 2023

Figure List

Figure 10‑1: Transcatheter Heart Valve Replacement Procedures Covered

Figure 10‑2: Transcatheter Heart Valve Replacement Markets Covered

Figure 10‑3: Transcatheter Heart Valve Replacement Regions Covered, Global (1 of 2)

Figure 10‑4: Transcatheter Heart Valve Replacement Regions Covered, Global (2 of 2)

Figure 10‑5: Transcatheter Heart Valve Replacement Procedures by Segment, Global, 2020 – 2030

Figure 10‑6: Transcatheter Heart Valve Replacement Procedures by Region, Global, 2020 – 2030

Figure 10‑7: Transcatheter Heart Valve Replacement Procedures by Country, North America, 2020 – 2030

Figure 10‑8: Transcatheter Heart Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 10‑9: Transcatheter Heart Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 10‑10: Transcatheter Heart Valve Replacement Procedures by Country, Western Europe, 2020 – 2030

Figure 10‑11: Transcatheter Heart Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 10‑12: Transcatheter Heart Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 10‑13: Transcatheter Heart Valve Replacement Procedures by Country, Middle East, 2020 – 2030

Figure 10‑14: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 10‑15: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 10‑16: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 10‑17: Transcatheter Heart Valve Replacement Procedures by Country, Africa, 2020 – 2030

Figure 10‑18: Transcatheter Aortic Valve Replacement Procedures by Protection, Global, 2020 – 2030

Figure 10‑19: Transcatheter Aortic Valve Replacement Procedures by Region, Global, 2020 – 2030

Figure 10‑20: Transcatheter Aortic Valve Replacement Procedures by Country, North America, 2020 – 2030

Figure 10‑21: Transcatheter Aortic Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 10‑22: Transcatheter Aortic Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 10‑23: Transcatheter Aortic Valve Replacement Procedures by Country, Western Europe, 2020 – 2030

Figure 10‑24: Transcatheter Aortic Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 10‑25: Transcatheter Aortic Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 10‑26: Transcatheter Aortic Valve Replacement Procedures by Country, Middle East, 2020 – 2030

Figure 10‑27: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 10‑28: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 10‑29: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 10‑30: Transcatheter Aortic Valve Replacement Procedures by Country, Africa, 2020 – 2030

Figure 10‑31: TAVR with Cerebral Embolic Protection Procedures by Region, Global, 2020 – 2030

Figure 10‑32: TAVR with Cerebral Embolic Protection Procedures by Country, North America, 2020 – 2030

Figure 10‑33: TAVR with Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 10‑34: TAVR with Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 10‑35: TAVR with Cerebral Embolic Protection Procedures by Country, Western Europe, 2020 – 2030

Figure 10‑36: TAVR with Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 10‑37: TAVR with Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 10‑38: TAVR with Cerebral Embolic Protection Procedures by Country, Middle East, 2020 – 2030

Figure 10‑39: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 10‑40: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 10‑41: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 10‑42: TAVR with Cerebral Embolic Protection Procedures by Country, Africa, 2020 – 2030

Figure 10‑43: TAVR without Cerebral Embolic Protection Procedures by Region, Global, 2020 – 2030

Figure 10‑44: TAVR without Cerebral Embolic Protection Procedures by Country, North America, 2020 – 2030

Figure 10‑45: TAVR without Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 10‑46: TAVR without Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 10‑47: TAVR without Cerebral Embolic Protection Procedures by Country, Western Europe, 2020 – 2030

Figure 10‑48: TAVR without Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 10‑49: TAVR without Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 10‑50: TAVR without Cerebral Embolic Protection Procedures by Country, Middle East, 2020 – 2030

Figure 10‑51: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 10‑52: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 10‑53: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 10‑54: TAVR without Cerebral Embolic Protection Procedures by Country, Africa, 2020 – 2030

Figure 10‑55: Transcatheter Pulmonary Valve Replacement Procedures by Region, Global, 2020 – 2030

Figure 10‑56: Transcatheter Pulmonary Valve Replacement Procedures by Country, North America, 2020 – 2030

Figure 10‑57: Transcatheter Pulmonary Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 10‑58: Transcatheter Pulmonary Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 10‑59: Transcatheter Pulmonary Valve Replacement Procedures by Country, Western Europe, 2020 – 2030

Figure 10‑60: Transcatheter Pulmonary Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 10‑61: Transcatheter Pulmonary Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 10‑62: Transcatheter Pulmonary Valve Replacement Procedures by Country, Middle East, 2020 – 2030

Figure 10‑63: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 10‑64: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 10‑65: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 10‑66: Transcatheter Pulmonary Valve Replacement Procedures by Country, Africa, 2020 – 2030

Figure 10‑67: Transcatheter Heart Valve Replacement Market by Segment, Global, 2020 – 2030 (US$M)

Figure 10‑68: Transcatheter Heart Valve Replacement Market by Region, Global, 2020 – 2030 (US$M)

Figure 10‑69: Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030

Figure 10‑70: Units Sold by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030

Figure 10‑71: Average Selling Price by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 (US$)

Figure 10‑72: Market Value by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 (US$M)

Figure 10‑73: Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030

Figure 10‑74: Units Sold by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030

Figure 10‑75: Average Selling Price by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 (US$)

Figure 10‑76: Market Value by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 (US$M)

Figure 10‑77: Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030

Figure 10‑78: Units Sold by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030

Figure 10‑79: Average Selling Price by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 (US$)

Figure 10‑80: Market Value by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 (US$M)

Figure 10‑81: Leading Competitors, Transcatheter Heart Valve Replacement Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology